Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.”

Detalles Bibliográficos
Autores principales: Fiorentino, Giuseppe, Coppola, Antonietta, Izzo, Raffaele, Annunziata, Anna, Bernardo, Mariano, Lombardi, Angela, Trimarco, Valentina, Santulli, Gaetano, Trimarco, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467817/
https://www.ncbi.nlm.nih.gov/pubmed/36120704
http://dx.doi.org/10.1016/j.eclinm.2022.101636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467817/
https://www.ncbi.nlm.nih.gov/pubmed/36120704
http://dx.doi.org/10.1016/j.eclinm.2022.101636

Ejemplares similares